Lin Chen

发表

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway

P. Lu, S. Fan, W. Ongkeko, 2010, Hepatology.

Octamer 4 ( Oct 4 ) Mediates Chemotherapeutic Drug Resistance in Liver Cancer Cells Through a Potential Oct 4 – AKT – ATP-Binding Cassette G 2 Pathway

P. Lu, S. Fan, W. Ongkeko, 2010 .

Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver

S. Fan, X. Q. Wang, C. Lo, 2012, Hepatology.

CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency

X. Q. Wang, A. Xu, C. Lo, 2016, Cell Death and Differentiation.

Epigenetic Regulation of Pluripotent Genes Mediates Stem Cell Features in Human Hepatocellular Carcinoma and Cancer Cell Lines

S. Fan, S. Tsao, X. Q. Wang, 2013, PloS one.

Title Epigenetic regulation of pluripotent genes mediates stem cell features in human hepatocellular carcinoma and cancer cell lines

S. Fan, S. Tsao, X. Q. Wang, 2013 .

Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma

X. Q. Wang, P. Olson, W. Xia, 2018, Oncotarget.

Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells

X. Q. Wang, C. Lo, T. Cheung, 2017, Oncotarget.

Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1–Stat3

X. Q. Wang, A. Xu, C. Lo, 2017, Molecular Cancer Therapeutics.

Characterization of Cell Cycle Phase-Based Micrornas in Pluripotency and Differentiation

X. Q. Wang, C. Lo, M. Garcia-Barceló, 2017 .